| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.26 | 5e-07 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |